Evidence map›Paper›PMID 40643450›Full record

ReviewMagyar onkologia2025

[New developments in the radiotherapy for head and neck cancer].

Zoltán Takácsi-Nagy

Abstract readReviewEnglish Abstract
In one paragraph

Review in Magyar onkologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Zoltán Takácsi-NagySugárterápiás Központ, Országos Onkológiai Intézet, Budapest, Hungary. takacsi@oncol.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of head and neck tumours is rising significantly worldwide. Radiotherapy has a significant role in their treatment, not only after surgery, but also as a definitive treatment, as an organ-preserving modality. Nowadays, the incidence of oropharyngeal tumours caused by the human papillomavirus is increasing sharply. They are characterised by a very good therapeutic response, including radiosensitivity, which has led to a number of deintensification trials being carried out or ongoing. Over the past decade, irradiation methods and techniques have improved considerably and changes in therapy have been made to improve the effectiveness of treatment and reduce side effects. Newer treatment options include adaptive irradiation, better definition of the target volume, the use of hadrons, stereotactic irradiation and the rise of artificial intelligence. In the following review, the results of the major publications on the above topics will provide an overview of modern and new therapeutic techniques in the field of radiotherapy of head and neck tumours.

Indexed as

Head and Neck NeoplasmsArtificial IntelligenceHumansRadiosurgeryRadiotherapy Planning, Computer-Assisted

Identifiers

PMID40643450
PMCPMC12255505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.